Irreversible electroporation: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

15

Conditions studied

0

US states with sites

2

Countries

Phase breakdown

Phase 2 1 Not applicable 1

Conditions being studied

Condition	Trials
Anal Cancer	1
Bladder Cancer	1
Cervical Cancer	1
Colorectal Carcinoma	1
Colorectal cancer	1
Lung Cancer (Including Metastatic Cancer)	1
Lung cancer	1
Neoplasm Recurrence, Local	1
Ovarian Cancer	1
Pancreatic Adenocarcinoma Locally Advanced	1
Pancreatic cancer	1
Pelvic Cancer	1
Pelvic Tumor Recurrence	1
Prostate Cancer	1
Renal Cancer	1

Recruiting trials involving Irreversible electroporation

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
NCT07306273 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
NCT07782164 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Irreversible electroporation?

2 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.